BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2783245)

  • 1. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
    Dillehay DL; Shealy YF; Lamon EW
    Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice.
    Schleicher RL; Moon RC; Patel MK; Beattie CW
    Cancer Res; 1988 Mar; 48(6):1465-9. PubMed ID: 3345519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting passive monoclonal antibody therapy of Moloney sarcoma in BALB/c mice.
    Kennel SJ; Lankford PK; Flynn KM; Winegar R
    Cancer Res; 1985 Aug; 45(8):3782-9. PubMed ID: 2410101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ; Jenkinson EJ; Owen JJ
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced inhibition of Moloney sarcoma virus-transformed cells: requirement for T-cells.
    Skicki-Mullen MB; Markovic SN; Murasko DM
    Cancer Res; 1989 Feb; 49(3):522-7. PubMed ID: 2463077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM; Knight RA
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines.
    McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI
    Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Moloney murine sarcoma virus tolerance in adult mice by anti-CD4 monoclonal antibody treatment.
    Biasi G; Mazzocchi M; Facchinetti A; Panozzo M; Zanovello P; Collavo D; Chieco-Bianchi L
    Cancer Res; 1990 Sep; 50(17 Suppl):5703S-5706S. PubMed ID: 2167167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM; Shealy YF; Penner JD; Jiang H
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice.
    Forni G; Cerruti Sola S; Giovarelli M; Santoni A; Martinetto P; Vietti D
    J Natl Cancer Inst; 1986 Mar; 76(3):527-33. PubMed ID: 3081748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice.
    Halter SA; Fraker LD; Adcock D; Vick S
    Cancer Res; 1988 Jul; 48(13):3733-6. PubMed ID: 3163940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serologic comparison of Moloney lymphoma cell surface and Moloney oncornavirus antigens.
    Humphrey D; Tsukamoto-Adey A; Witte OM; Fox R; Jerabek L; Weissman IL
    J Immunol; 1979 Jul; 123(1):412-8. PubMed ID: 87479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.